FDA NDC Directory · JSON-LD · Markdown

COSENTYX

NDC 0078-0639 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic namesecukinumab
Labeler / ManufacturerNovartis Pharmaceuticals Corporation
Marketing categoryBiologic License Application · App BLA125504
Dosage form / routeINJECTION · SUBCUTANEOUS
Active ingredientsSECUKINUMAB (150 mg/mL)
Marketing started20150121
Package count4

External sources

Source: openFDA. Public-domain (CC0).